Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00107029 · ClinicalTrials.gov registry record

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

A clinical trial of HIV Infection, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
113
Enrollment target
10
Study locations

NCT00107029 is a study of HIV Infection that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 113 participants, below the 241-participant average among 73 other HIV Infection trials with a reported enrollment target (53% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00107029, a study of HIV Infection, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
113 participants
Enrollment target
10
Study locations

Study Summary

This protocol is a study of HIV+ young people who were identified as having certain HIV-1 specific T-cell responses and genetic markers while previously enrolled in the 5-year longitudinal adolescent study, "REACH." Blood samples will be collected, a medical and medication history and physical examination will be performed every 6 months for a total of 2 years.

Conditions Studied

HIV Infection

Study Locations (10)

Florida

  • Children's Diagnostic and Treatment Center - Fort Lauderdale
  • University of Miami-Jackson Memorial Medical Center - Miami

New York

  • Mount Sinai Medical Center - New York
  • Children's Hospital at Montefiore Medical Center - The Bronx

California

  • Children's Hospital of Los Angeles - Los Angeles

District of Columbia

  • Children's National Medical Center - Washington D.C.

Illinois

  • Cook County Children's Hospital - Chicago

Louisiana

  • Tulane Medical Center - New Orleans

Maryland

  • University of Maryland - Baltimore

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2002-12
Est. Completion 2005-09

Sponsor

University of North Carolina, Chapel Hill

1,109 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00107029

The ClinicalTrials.gov registry entry for NCT00107029 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 73 other HIV Infection trials with a reported enrollment target (53% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infection appearing as the primary indexed condition, and to 0 interventions.

NCT00107029 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Florida, New York, California.

Frequently Asked Questions

What is clinical trial NCT00107029 about?

NCT00107029 is a clinical study titled "Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth". This protocol is a study of HIV+ young people who were identified as having certain HIV-1 specific T-cell responses and genetic markers while previously enrolled in the 5-year longitudinal adolescent study, "REACH." Blood samples will be collected, a medical and medication history and physical exami...

What is the current status of trial NCT00107029?

This trial is currently completed. The enrollment target is 113 participants. The study started on 2002-12. Estimated completion is 2005-09.

What conditions does trial NCT00107029 study?

This clinical trial studies the following conditions: HIV Infection.

Who is sponsoring clinical trial NCT00107029?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00107029 being conducted?

This trial has 10 study locations across California, District of Columbia, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infection

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.